Eyeworld

MAR 2012

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/78716

Contents of this Issue

Navigation

Page 14 of 167

EXCEPTIONAL SAFETY, ENHANCED FLAP STABILITY AND FASTER VISUAL RECOVERY 1-2 Experience the clinical benefi ts of the 5th-generation iFS Femtosecond Laser The iFS Laser is an essential component of the iLASIK Platform, and only iLASIK Technology provides truly customized treatments to help you take more of your patients beyond 20/20.† Scan this code or visit www.amo-ilasik.com/proven to learn how to bring proven technology, that's good enough for NASA, to your patients. 20/16 results delivered with excimer laser: clinical studies sent to the FDA via P930016 supplement 021. References † 1. Knorz MC, Vossmerbaeumer U. Comparison of fl ap adhesion strength using the AMADEUS microkeratome and the IntraLase iFS femtosecond laser in rabbits. J Refract Surg. 2008;24(9):875-878. 2. Probst L, Lehr J. Changes in visual acuity and results and testing after LASIK. Paper presented at: American Society of Cataract and Refractive Surgery; March 2011; San Diego, CA. Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for specifi ed reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunodefi ciency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a fl ap on the surface of the cornea, potential side effects may include fl ap related complications. Patients are requested to consult with their eye care professional and Patient Information Booklet regarding the potential risks and benefi ts for laser refractive surgery, results may vary for each individual patient. Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors. Please see brief statement on adjacent page. ©2012 Abbott Medical Optics Inc. iFS and iLASIK are registered trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affi liates. 2011.07.06-RF3700

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - MAR 2012